The thinking around carrier screening is changing, with the leading medical associations agreeing that all women who are considering pregnancy or are currently pregnant should be offered carrier screening for cystic fibrosis and spinal muscular atrophy. The American Congress of Obstetricians and Gynecologists (ACOG) and American College of Medical Genetics and Genomics (ACMG) currently have guidelines related to screening for more specific conditions.
With a wide array of testing choices, Labcorp can help meet a wide array of patient needs. Our carrier screening offerings include Inheritest—with six panels: 500 PLUS, Comprehensive, Ashkenazi Jewish, Society-guided, Core and CF/SMA —and many single-gene tests for patients who may only want to screen for a specific disorder, such as cystic fibrosis, spinal muscular atrophy, or fragile X syndrome.
Should a patient receive a positive screen result, we offer full-gene sequencing for her reproductive partner to identify more disorder-causing variants and at-risk pregnancies.
Additionally, using Labcorp as your single source for carrier screening, prenatal testing (eg, serum screening and noninvasive prenatal testing), prenatal diagnostic testing, and hereditary cancer testing creates efficiencies in ordering and processing tests for you, your staff, and your patients.
Labcorp is one of the only companies that can offer this true continuity of care. Explore other testing options and services below.